文献速递骨软组织肉瘤与黑色素瘤

104例骨肉瘤肺转移患者的生存分析

[Survival analysis of 104 cases of osteosarcoma with lung metastases].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2017-01-01

回顾性分析2007年4月至2015年9月104例骨肉瘤肺转移患者的临床资料,采用Kaplan-Meier法、Log rank检验和Cox回归分析预后因素。患者1年、2年、5年生存率分别为93.3%、61.5%、11.5%,中位生存时间33个月。肺转移灶数目、一线化疗客观缓解和肺转移治疗方法为独立预后因素。

要点

  • 104例骨肉瘤肺转移患者1年、2年、5年生存率分别为93.3%、61.5%、11.5%,中位生存时间33个月。
  • 肺转移灶数目、一线化疗客观缓解、肺转移治疗方法为独立预后因素。
  • 手术和辅助化疗可有效延长骨肉瘤肺转移患者的生存时间。

核心结论

  • 晚期肺转移且积极治疗的骨肉瘤患者预后较好。
  • 手术和辅助化疗可有效延长骨肉瘤肺转移患者的生存时间。

研究设计与样本

  • 回顾性分析2007年4月至2015年9月104例骨肉瘤肺转移患者的临床资料。
  • 采用Kaplan-Meier法和Log rank检验进行单因素分析,Cox回归进行多因素分析。

主要发现

  • 104例骨肉瘤肺转移患者1年、2年、5年生存率分别为93.3%、61.5%、11.5%,中位生存时间33个月。
  • 单因素分析显示肺转移灶数目、一线化疗客观缓解、肺转移治疗方法为显著预后因素,而性别、年龄、肺转移时间、其他转移时间无显著差异(P>0.05)。
  • 多因素分析显示肺转移灶数目、一线化疗客观缓解、肺转移治疗方法为独立显著预后因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the prognosis of osteosarcoma patients with lung metastases and its correlated factors. Methods: The clinical data of 104 osteosarcoma patients with lung metastasis from April 2007 to September 2015 were retrospectively analyzed. Univariate analysis was performed using Kaplan-Meier and Log rank test. Multivariate Cox regression was applied to analyze independent prognostic factor for patient survival. Results: The one-year, two-year and five-year survival rates of the 104 osteosarcoma patients with lung pulmonary metastasis were 93.3%, 61.5% and 11.5%, respectively, and the median survival time was 33 months. The univariate analysis revealed that number of lung metastases, objective response of first-line chemotherapy and therapeutic methods for lung metastases were significant prognostic factors for patient survival, whereas gender, age, time to lung metastasis and time to other metastasis were not (P>0.05). The multivariate analysis indicated that number of lung metastases, objective response of first-line chemotherapy and therapeutic methods for lung metastases were independent significant prognostic factors for patient survival. Conclusions: The prognosis of osteosarcoma patients with advanced lung metastases and active treatment is better. Surgery and adjuvant chemotherapy could effectively prolong survival time for osteosarcoma patients with pulmonary metastasis.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ren J, Xu YF, Kuang TH, et al. [Survival analysis of 104 cases of osteosarcoma with lung metastases]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28550665. doi:10.3760/cma.j.issn.0253-3766.2017.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。